IM Cannabis Corp Stock News

TORONTO and GLIL YAM, Israel , April 11, 2025 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IM Cannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, today announced the following corporate updates.     Nasdaq Notification Letter The Company has received a written notification (the "Notification Letter") from the Nasdaq St...

IM Cannabis Corp. (NASDAQ:IMCC ) Q4 2024 Earnings Conference Call March 31, 2025 9:00 AM ET Company Participants Anna Taranko - Director of Investor and Public Relations Oren Shuster - Chairman and Chief Executive Officer Uri Birenberg - Chief Financial Officer Conference Call Participants Aaron Grey - Alliance Global Partners Operator Good morning and welcome to IM Cannabis' Fourth Quarter and...

Q4 2024 Caps a Year of Strategic and Operational Improvements for IMC with 25% Revenue Growth, 42% decrease in Operating Expenses, and $0.5M Adjusted EBITDA Profit TORONTO and GLIL YAM, Israel , March 31, 2025 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, is pleased to announce its financial results for the four...

TORONTO and GLIL YAM, Israel , March 20, 2025 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company," "IMCannabis," or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the fourth quarter and full year 2024 ended December 31, 2024, on Monday, March 31, 2025 before the market opens. The Company...

TORONTO and GLIL YAM, Israel, Jan. 17, 2025 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ: IMCC) (CSE: IMCC), a leading medical cannabis company with operations in Israel and Germany, announces that it has changed its auditor from Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global (the "Predecessor Auditor") to Fahn Kanne & Co. Grant Thornton Israel (the "Succes...

IM Cannabis Corp. (NASDAQ:IMCC ) Q3 2024 Earnings Conference Call November 14, 2024 9:00 AM ET Company Participants Anna Taranko - Director of Investor and Public Relations Oren Shuster - Chief Executive Officer Uri Birenberg - Chief Financial Officer Conference Call Participants Operator Good morning, and welcome to IM Cannabis' Third Quarter 2024 Earnings Conference Call. Today's conference c...

IMC pairs a +12% increase in revenue with a -16% decrease in the total operating expenses, building a solid foundation to deliver in 2025. TORONTO and GLIL YAM, Israel , Nov. 14, 2024 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announced its financial results today for the third quarter ended September 30, 2024.

TORONTO and GLIL YAM, Israel , Nov. 6, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the third 2024 ended September 30, 2024, on November 14, 2024, before the market opens. The Company will host a zoom web confer...